ZIOPHARM, Inc. Elects George B. Abercrombie, former CEO of Hoffmann-La Roche AG, to Board of Directors
4/6/2010 10:23:54 AM
More...
|
AstraZeneca AB, Merck & Co., Inc. (MRK), Novartis AG, H. Lundbeck A/S, Hoffmann-La Roche AG, And GlaxoSmithKline (GSK) Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulation of Drugs
2/4/2010 12:52:53 PM
More...
|
Hoffmann-La Roche AG (JOBS) Says New Data Confirm Mabthera, Actemra Work
10/27/2008 6:54:39 AM
More...
|
Hoffmann-La Roche AG's PEGASYS(R) Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered "Cured"
5/22/2007 2:10:14 AM
More...
|
Roche and Synosis Therapeutics Announce Partnership To Explore Potential Of Five Compounds Targeting The Central Nervous System
1/4/2007 11:42:40 AM
More...
|
Hoffmann-La Roche AG Release: Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit In Patients With Advanced Breast Cancer
12/15/2006 11:02:50 AM
More...
|
ArQule, Inc. (ARQL) Initiates Phase 1 Trial With ARQ 171, Provides Enrollment Update On ARQ 501 And ARQ 197
12/6/2006 11:30:21 AM
More...
|
Roche (RHHBY) And InterMune, Inc. (ITMN) Sign $530M Agreement To Collaborate On The Research, Development And Commercialization Of Hepatitis C Protease Inhibitors
10/16/2006 5:07:09 PM
More...
|
Herceptin "Linked To Heart Risk"
8/15/2006 9:48:29 AM
More...
|
Four Abstracts On Roche (RHHBY)'s C.E.R.A. Accepted For Presentation At Leading European Nephrology Congress
7/6/2006 3:18:33 PM
More...
|
|